Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1975-7-18
pubmed:abstractText
Normal mouse spleen cells were fractionated in dishes coated with thin layers of DNP-gelatin or NIP-gelatin, which were insoluble at 4 degrees C. Highly viable cells were recovered from the dishes by melting the gel at 37 degrees C. NIP3- gelatin layers bound approximately 0.1% and DNP4-gelatin layers 0.5% of normal spleen cells. Increasing numbers of low affinity cells were bound with increasing DNP density of the adsorbent. The binding to insoluble DNP-gelatin was hapten-specific since it was inhibited by DNP-lysine, soluble DNP-gelatin or DNP-BSA but not by soluble gelatin or bovine serum albumin (BSA). It was also inhibited by a polyvalent rabbit antimouse Ig. DNP-gelatin was detected on the surface of cells recovered from DNP-gelatin-coated dishes by 125-I-labeled anti-DNP Ig. The cell surface bound DNP-gelatin could be removed by treatment with collagenase. Collagenase treatment did not detectably affect cell viability or surface receptors. More than 90% of DNP-gelatin binding cells were labeled with a polyvalent 125-I-labeled antimouse Ig before or after collagenase treatment under conditions known to label B lymphocytes. Furthermore, the specific antigen-binding capacity of the purified cell populations could be demonstrated after treatment with collagenase. Purified DNP4-gelatin binding cells contained more than 100 times as many DNP-RFC than unfractionated cells. The enrichment of NIP-RFC in the cell population recovered from NIP3 gelatin-coated dishes was more than 200-fold.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-14812273, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4104294, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4110525, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4114858, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4124982, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4137202, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4137510, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4139227, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4540327, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4540455, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4568186, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4582160, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4591178, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4611686, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4912957, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4913207, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4927599, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4934503, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-4942707, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-5101790, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-5289374, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-5782770, http://linkedlifedata.com/resource/pubmed/commentcorrection/47891-5939478
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
141
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1004-14
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1975
pubmed:articleTitle
Separation of antigen-specific lymphocytes. I. Enrichment of antigen-binding cells.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.